Similar articles

• Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis.

  Chang A, Tourtellotte WW, Rudick R, Trapp BD. Chang A, et al. N Engl J Med. 2002 Jan 17;346(3):165-73. doi: 10.1056/NEJMoa010994. N Engl J Med. 2002. PMID: 11796850
• Visualizing the cause of gray matter atrophy in multiple sclerosis.

  Richert ND, Kraft E, Stüve O. Richert ND, et al. Arch Neurol. 2009 Feb;66(2):159-60. doi: 10.1001/archneurol.2008.563. Arch Neurol. 2009. PMID: 19204151 No abstract available.
• The pathologic substrate of magnetic resonance alterations in multiple sclerosis.

  Lassmann H. Lassmann H. Neuroimaging Clin N Am. 2008 Nov;18(4):563-76, ix. doi: 10.1016/j.nic.2008.06.005. Neuroimaging Clin N Am. 2008. PMID: 19068402 Review.
• Contribution of white matter lesions to gray matter atrophy in multiple sclerosis: evidence from voxel-based analysis of T1 lesions in the visual pathway.

  Sepulcre J, Goñi J, Masdeu JC, Bejarano B, Vélez de Mendizábal N, Toledo JB, Villoslada P. Sepulcre J, et al. Arch Neurol. 2009 Feb;66(2):173-9. doi: 10.1001/archneurol.2008.562. Arch Neurol. 2009. PMID: 19204153
• The neuropathology of multiple sclerosis.

  Ludwin SK. Ludwin SK. Neuroimaging Clin N Am. 2000 Nov;10(4):625-48 ,vii. Neuroimaging Clin N Am. 2000. PMID: 11359716 Review.